Literature DB >> 18581113

Present and future of clinical cardiovascular PET imaging in Europe--a position statement by the European Council of Nuclear Cardiology (ECNC).

D Le Guludec1, R Lautamäki, J Knuuti, J J Bax, F M Bengel.   

Abstract

This position statement was prepared by the European Council of Nuclear Cardiology and summarises the current and future potential of PET as a clinical cardiovascular diagnostic imaging tool. The first section describes how methodological developments have positively influenced the transition of PET from a research tool towards a clinical diagnostic test. In the second section, evidence in support of its superior diagnostic accuracy, its value to guide decision making and to predict outcome and its cost effectiveness is summarised. The third section finally outlines new PET-based approaches and concepts, which will likely influence clinical cardiovascular medicine in the future. The notion that integration of cardiac PET into healthcare systems and disease management algorithms will advance quality of care is increasingly supported by the literature highlighted in this statement.

Mesh:

Year:  2008        PMID: 18581113     DOI: 10.1007/s00259-008-0859-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  123 in total

1.  Impact of myocardial perfusion imaging with PET and (82)Rb on downstream invasive procedure utilization, costs, and outcomes in coronary disease management.

Authors:  Michael E Merhige; William J Breen; Victoria Shelton; Teresa Houston; Brian J D'Arcy; Anthony F Perna
Journal:  J Nucl Med       Date:  2007-07       Impact factor: 10.057

2.  Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability.

Authors:  T H Marwick; C Zuchowski; M S Lauer; M A Secknus; J Williams; B W Lytle
Journal:  J Am Coll Cardiol       Date:  1999-03       Impact factor: 24.094

3.  Comparative performance of gated perfusion SPECT wall thickening, delayed thallium uptake, and F-18 fluorodeoxyglucose SPECT in detecting myocardial viability.

Authors:  E G DePuey; M Ghesani; M Schwartz; M Friedman; K Nichols; H Salensky
Journal:  J Nucl Cardiol       Date:  1999 Jul-Aug       Impact factor: 5.952

4.  Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans.

Authors:  P Chareonthaitawee; P A Kaufmann; O Rimoldi; P G Camici
Journal:  Cardiovasc Res       Date:  2001-04       Impact factor: 10.787

5.  (18)Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials.

Authors:  James H F Rudd; Kelly S Myers; Sameer Bansilal; Josef Machac; Ash Rafique; Michael Farkouh; Valentin Fuster; Zahi A Fayad
Journal:  J Am Coll Cardiol       Date:  2007-08-13       Impact factor: 24.094

6.  F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).

Authors:  Rob S B Beanlands; Graham Nichol; Ella Huszti; Dennis Humen; Normand Racine; Michael Freeman; Karen Y Gulenchyn; Linda Garrard; Robert deKemp; Ann Guo; Terrence D Ruddy; Francois Benard; André Lamy; Robert M Iwanochko
Journal:  J Am Coll Cardiol       Date:  2007-10-10       Impact factor: 24.094

7.  Effect of aging on myocardial perfusion reserve.

Authors:  N G Uren; P G Camici; J A Melin; A Bol; B de Bruyne; J Radvan; I Olivotto; S D Rosen; M Impallomeni; W Wijns
Journal:  J Nucl Med       Date:  1995-11       Impact factor: 10.057

8.  Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease.

Authors:  R E Patterson; R L Eisner; S F Horowitz
Journal:  Circulation       Date:  1995-01-01       Impact factor: 29.690

9.  Quantitative evaluation of a comprehensive motion, resolution, and attenuation correction program: initial experience.

Authors:  P Rigo; P Van Boxem; J Foulon; M Safi; J Engdahl; J Links
Journal:  J Nucl Cardiol       Date:  1998 Sep-Oct       Impact factor: 5.952

10.  Quantification of regional myocardial blood flow in vivo with H215O.

Authors:  S R Bergmann; K A Fox; A L Rand; K D McElvany; M J Welch; J Markham; B E Sobel
Journal:  Circulation       Date:  1984-10       Impact factor: 29.690

View more
  12 in total

Review 1.  Myocardial perfusion scintigraphy: past, present and future.

Authors:  A Notghi; C S Low
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 2.  Clinical use of quantitative cardiac perfusion PET: rationale, modalities and possible indications. Position paper of the Cardiovascular Committee of the European Association of Nuclear Medicine (EANM).

Authors:  Roberto Sciagrà; Alessandro Passeri; Jan Bucerius; Hein J Verberne; Riemer H J A Slart; Oliver Lindner; Alessia Gimelli; Fabien Hyafil; Denis Agostini; Christopher Übleis; Marcus Hacker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-02-05       Impact factor: 9.236

3.  Cardiac PET-CT: advanced hybrid imaging for the detection of coronary artery disease.

Authors:  P Knaapen; S de Haan; O S Hoekstra; R Halbmeijer; Y E Appelman; J G J Groothuis; E F Comans; M R Meijerink; A A Lammertsma; M Lubberink; M J W Götte; A C van Rossum
Journal:  Neth Heart J       Date:  2010-02       Impact factor: 2.380

4.  Validation of pixel-wise parametric mapping of myocardial blood flow with ¹³NH₃ PET in patients with hypertrophic cardiomyopathy.

Authors:  Roberto Sciagrà; Alessandro Passeri; Fabrizio Cipollini; Helga Castagnoli; Iacopo Olivotto; Cyrill Burger; Franco Cecchi; Alberto Pupi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-06-27       Impact factor: 9.236

5.  Hybrid cardiac imaging: SPECT/CT and PET/CT. A joint position statement by the European Association of Nuclear Medicine (EANM), the European Society of Cardiac Radiology (ESCR) and the European Council of Nuclear Cardiology (ECNC).

Authors:  Albert Flotats; Juhani Knuuti; Matthias Gutberlet; Claudio Marcassa; Frank M Bengel; Philippe A Kaufmann; Michael R Rees; Birger Hesse
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01       Impact factor: 9.236

Review 6.  "Vascular inflammation and cardiovascular disease: review about the role of PET imaging".

Authors:  Antonio Maria Sammartino; Raffaele Falco; Andrea Drera; Francesco Dondi; Pietro Bellini; Francesco Bertagna; Enrico Vizzardi
Journal:  Int J Cardiovasc Imaging       Date:  2022-10-18       Impact factor: 2.316

7.  First experience of combined cardiac PET/64-detector CT angiography with invasive angiographic validation.

Authors:  Ashley M Groves; Marie-Elsya Speechly-Dick; Irfan Kayani; Francesca Pugliese; Raymondo Endozo; Jean McEwan; Leon J Menezes; Said B Habib; Elizabeth Prvulovich; Peter J Ell
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-07-18       Impact factor: 9.236

8.  Coronary risk factors and myocardial blood flow in patients evaluated for coronary artery disease: a quantitative [15O]H2O PET/CT study.

Authors:  Ibrahim Danad; Pieter G Raijmakers; Yolande E Appelman; Hendrik J Harms; Stefan de Haan; Mijntje L P van den Oever; Cornelis van Kuijk; Cornelis P Allaart; Otto S Hoekstra; Adriaan A Lammertsma; Mark Lubberink; Albert C van Rossum; Paul Knaapen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-10-18       Impact factor: 9.236

9.  Impact of preoperative positron emission tomography in patients with severely impaired LV-function undergoing surgical revascularization.

Authors:  Johannes Boehm; Felix Haas; Robert Bauernschmitt; Stefan Wagenpfeil; Bernhard Voss; Markus Schwaiger; Rüdiger Lange
Journal:  Int J Cardiovasc Imaging       Date:  2010-01-21       Impact factor: 2.357

Review 10.  Quantitative cardiac positron emission tomography: the time is coming!

Authors:  Roberto Sciagrà
Journal:  Scientifica (Cairo)       Date:  2012-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.